Lethal neonatal coagulopathy after maternal ingestion of a superwarfarin.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 23884275.
- Also identified by DOI 10.1097/AOG.0b013e31829267c4.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Brodifacoum, a superwarfarin, is a common household agent used for rodenticides. We present a case of maternal brodifacoum ingestion that resulted in neonatal death. A 19-year-old primigravid woman presented at 32 weeks of gestation with spontaneous mucosal bleeding. Her fetus showed evidence of acidosis on external fetal monitoring. Laboratory values were consistent with maternal coagulopathy. After correction of the coagulopathy, the patient was taken for urgent cesarean delivery. The neonate showed evidence of fetal coagulopathy and died at 4 days of life. Brodifacoum is a dangerous household chemical that, if ingested, can result in significant morbidity and mortality for both mother and neonate. Increased awareness of the serious and potentially lethal effects of brodifacoum is important.
Medical subject headings
- 4-Hydroxycoumarins
- Anticoagulants
- Blood Coagulation Disorders
- Infant, Newborn, Diseases
- Prenatal Exposure Delayed Effects